Ken Griffin Sanara Med Tech Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 20,493 shares of SMTI stock, worth $686,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,493Holding current value
$686,515% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding SMTI
# of Institutions
43Shares Held
812KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$6.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA173KShares$5.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA88.3KShares$2.96 Million0.0% of portfolio
-
State Street Corp Boston, MA58.7KShares$1.97 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.5KShares$1.36 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $278M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...